XPeng

XPEV.US Weekly Report · 2026-W37

XPEV.US declined 3.74% to $10.54 this week, hitting a 52-week low. While the IRON humanoid robot’s official production line commissioning marks the company’s expansion into advanced manufacturing, the Q2 earnings report showing accelerating losses weighed heavily on the stock. Institutional ratings remain concentrated in buy territory (14 buy ratings), with an average target price of $19.33 implying 82% upside, creating a stark contradiction with the depressed stock price.

Price Action

The intraweek movement was consistently weak. Opening at $11.30 on Monday (Sept 8), the stock declined throughout the session. Tuesday saw the low of $10.46 within the week. Wednesday hit a near-52-week low of $10.31. Thursday saw a modest rebound to $10.54 close. From last Friday’s $10.95, the week’s cumulative decline was 3.74%.

Intraweek volatility was confined: the range ($10.70 – $10.46) relative to the opening ($10.58) represents just 2.27% amplitude, indicating consensus bearish sentiment without significant reversal attempts. The Thursday bounce proved insufficient to establish support, suggesting downward momentum remains intact.

Weekly trading volume reached 34.32 million shares. The turnover rate of 1.52% is moderate relative to the company’s 670.84M circulating shares, showing no extreme trading anomalies.

Valuation Positioning

P/B Valuation: Currently at 2.53x, an exceptionally low level. According to the valuation data, this falls at the 4.16th percentile over the past 3 years—meaning the stock traded higher 95.84% of the time. This reflects extreme market pessimism toward XPeng’s asset value.

However, context matters: the automotive sector median P/B is just 0.87x, and XPeng at 2.53x still commands a significant premium. The market, despite its pessimism, still ascribes value differentiation to XPeng—likely pricing in expectations for autonomous driving and robotics breakthroughs.

P/E Valuation: -22.47x (negative). This reflects the company’s loss-making status, making traditional earnings multiples inapplicable.

Earnings Delivery

Two consecutive quarters of accelerating losses signal deteriorating fundamentals.

Q2 2026 Results:

• EPS: -$0.27
• Revenue: $2.906B, up 14.06% YoY, up 53.8% QoQ from Q1’s $1.886B
• Net loss: -$196.8M, YoY loss expansion of 195.45% (prior year Q2 was profitable)
• ROE: -19.28%

Q1 2026 Comparison:

• EPS: -$0.27 (matching Q2)
• Revenue down 35.3% QoQ
• Net loss: -$258.1M
• ROE: -24.26%, even more negative

vs. Consensus: Latest EPS consensus estimate was -$0.119 (as of Aug 25). Actual Q2 EPS of -$0.27 missed expectations by 126%. The loss severity significantly exceeded institutional average expectations.

One mitigating detail: Q4 2025 posted +$0.0566 EPS and 5.08% ROE, proving the company is not structurally unable to profit—it is traversing a difficult cycle.

Capital Flow

Capital flows reveal an institutional-buy/retail-sell divergence.

Institutional Capital (large-cap trades): Net inflow. Inflows of 158.56 exceeded outflows of 83.52, yielding ~75 units net.

Mid-tier Capital: Net inflow. Inflows of 183.92 vs. outflows of 96.59, yielding ~87 units net.

Retail Capital: Net outflow. Inflows of 193.27 fell short of outflows of 233.23, resulting in ~40 units net outflow.

Interpretation: Institutional investors (combined large + mid-tier) are bottom-fishing at 52-week lows with cumulative net inflows exceeding 150 units; retail investors are capitulating into bearish sentiment. This reflects a fundamental disagreement in medium-to-long-term outlook—institutions favor longer-horizon prospects, retail focuses on near-term distress.

Institutional Ratings

The rating distribution broadcasts strong optimism, yet rating lag must not be overlooked.

Current Ratings (as of Sept 9):

• Buy: 14
• Hold: 3
• Under: 2
• Sell: 0
• Average Target Price: $19.33

Against the current price of $10.54, the target implies 82.6% upside. This creates a paradox: most institutions expect higher prices, yet the stock keeps hitting 52-week lows.

Lag Signal: The Sept 9 buy ratings persisted even as the stock had already fallen to $10.84, suggesting the ratings may reflect analysis from earlier in the summer that did not account for the recent acceleration in losses. The wide gap between consensus targets and current price likely reflects institutional confidence in autonomous driving and robotics commercialization 2–3 years out, not acceptance of near-term distress.

News Highlights

Recent headlines cluster around two themes:

Humanoid Robot Milestone: XPeng’s IRON advanced general-purpose humanoid officially rolled off the production line this week, with the manufacturing facility commissioned. This represents a significant engineering achievement and signals the company’s pivot toward robotics-as-a-business alongside EV operations. Multiple outlets noted that Chinese automakers (XPeng, NIO, Li Auto) are following Tesla’s bet on robots as the next major profit engine.

Geographic Expansion: The company’s first right-hand-drive G9L SUVs are now in production for the Australian market, marking XPeng’s international EV footprint expansion beyond the Chinese domestic base.

Stock Weakness Amid Achievement: Despite the humanoid milestone, XPeng hit multiple 52-week lows. Broker commentary noted the stock reached $10.73 (down 2% intraday) even as the robot announcement landed—a signal that equity markets are prioritizing near-term earnings distress over long-term technology optionality.

Analyst Coverage: Coverage remains constructive. One note cited AI-driven autonomous tech progress and maintained a Buy rating with a $96 price target. However, the wide gap between institutional targets and current price underscores the “show me” phase—words of encouragement from banks matter less than evidence of returning to profitability.

Semi-Solid Battery Pivot: Reports emerged that XPeng’s robotaxi program (Project Iron) is shifting to semi-solid battery technology as all-solid-state development lags—a technical pragmatism that acknowledges development timeline realities without fundamental breakthrough claims.

Industry Macro: Coverage of the broader Chinese EV sector notes a slowdown in domestic new energy vehicle (NEV) delivery growth, providing headwinds to all players. The humanoid pivot is partly a competitive response to slowing traditional EV markets.

Critical Contradictions

Several dimensions clash in ways that matter:

1. Valuation vs. Fundamentals: Historically low P/B (4th percentile over 3 years) meets accelerating quarterly losses. Cheap valuations should attract value investors, but mounting losses undermine the thesis, suggesting market skepticism about recovery trajectory.

2. Analyst Optimism vs. Stock Action: Fourteen buy ratings could not arrest a 52-week low. This typically signals either that ratings are stale or that short-term bearish sentiment has overwhelmed fundamental analysis. The next round of research updates may yield significant rating cuts.

3. Technology Achievement vs. Cash Crisis: IRON production commissioning is a genuine engineering win and signals diversification beyond EVs. Yet it occurs amid the worst quarterly losses in recent periods. The contradiction isn’t resolved—the market is waiting to see whether robotics eventually offset the EV margin collapse.

4. Institutional Accumulation vs. Stock Decline: Buy-side money flowing in but price falling suggests that although some long-term believers are building positions, selling pressure (retail exodus, short covering trades) dominates. The market has not yet found equilibrium.

In aggregate, XPEV embodies a “narrative tug-of-war”—bullish on 2–3 year autonomous/robotics upside, bearish on 2026 cash burn and profitability path. Investors are parsing which timeline and assumption set will prove decisive.